Problem: Your hospital wants to set up a translational project to use a whole genome sequencing service for newly diagnosed children with cancer. Both tumour and germline will be sequenced and the aim is to produce a clinical report and identify somatic targets for existing and novel therapies. How can I describe what I would tackle the clinical interpretation of results and ethical issues that may arise?